In The News
GlobeStar Therapeutics releases news regularly through press releases, the media, our social media, and in our Health Library. It’s our practice to let the world know what we are working on, our successes, and about our team.
Over the past few months, our news has been covered in publications that include: The Wall Street Journal, Yahoo! Finance, Marketwatch, Barrons, Google Finance, Stockwatch, The Pittsburgh Post-Gazette, WallStreetSelect, International Business Times, The Boston Herald, St Louis Star, Seattle Bulletin, Los Angeles Herald, and over 500 other online, broadcast, and print news outlets.
Please watch for our news, learn more about us, and feel free to reach out. As a proactive public company, GlobeStar Therapeutics will continue to release news in a timely fashion.
Greenwald’s experience in public relations and marketing will play a key role in the growth of AngioSoma RICHLAND, WA / ACCESSWIRE / April 19, 2021 / AngioSoma, Inc. (OTC PINK:SOAN) has hired Brooke Greenwald as its Chief Marketing Officer. Ms. Greenwald brings...
Farley’s experience in discovery and development will play a key role in the growth of AngioSoma. RICHLAND, WA / ACCESSWIRE / April 15, 2021 / AngioSoma, Inc. (OTC PINK:SOAN) has added William “Bill” Farley to its Board of Directors. Farley’s experience in discovery...
ANGIOSOMA AND ITS SUBSIDIARY SOMACEUTICALS ANNOUNCE AMENDED AND RESTATED EXECUTION OF GLOBAL LICENSE FOR MULTIPLE SCLEROSIS PATENT
Houston, TX, Feb. 11, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — AngioSoma Inc. (OTC: SOAN) (“AngioSoma” or the “Company”), through its wholly-owned subsidiary, SomaCeuticals, Inc., is pleased to announce that the Exclusive Global Multiple Sclerosis License Agreement...